{
    "organizations": [],
    "uuid": "0b6f993bf6b1b6ba9318eefe7e9c3ca26d8e6a17",
    "author": "",
    "url": "https://www.reuters.com/article/brief-fda-approves-ultragenyx-pharmaceut/brief-fda-approves-ultragenyx-pharmaceuticals-crysvita-to-treat-an-inherited-form-of-rickets-idUSFWN1RU161",
    "ord_in_thread": 0,
    "title": "BRIEF-FDA Approves Ultragenyx Pharmaceutical's Crysvita To Treat An Inherited Form Of Rickets",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 17, 2018 / 6:08 PM / Updated 7 minutes ago BRIEF-FDA Approves Ultragenyx Pharmaceutical's Crysvita To Treat An Inherited Form Of Rickets Reuters Staff 1 Min Read \nApril 17 (Reuters) - U.S. Food and Drug Administration: \n* U.S. FDA SAYS APPROVED CRYSVITA (BUROSUMAB) TO TREAT ADULTS & CHILDREN AGES 1 YEAR& OLDER WITH X-LINKED HYPOPHOSPHATEMIA, AN INHERITED FORM OF RICKETS \n* U.S. FDA SAYS GRANTED APPROVAL OF CRYSVITA TO ULTRAGENYX PHARMACEUTICAL INC Source text for Eikon: Further company coverage:",
    "published": "2018-04-17T21:06:00.000+03:00",
    "crawled": "2018-04-17T21:23:33.016+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "pm",
        "updated",
        "minute",
        "ago",
        "approves",
        "ultragenyx",
        "pharmaceutical",
        "crysvita",
        "treat",
        "inherited",
        "form",
        "rickets",
        "reuters",
        "staff",
        "min",
        "read",
        "april",
        "reuters",
        "food",
        "drug",
        "administration",
        "fda",
        "say",
        "approved",
        "crysvita",
        "burosumab",
        "treat",
        "adult",
        "child",
        "age",
        "year",
        "older",
        "hypophosphatemia",
        "inherited",
        "form",
        "rickets",
        "fda",
        "say",
        "granted",
        "approval",
        "crysvita",
        "ultragenyx",
        "pharmaceutical",
        "inc",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}